Healthcare - Biotechnology - NASDAQ - US
$ 2.58
45.8 %
$ 6.99 M
Market Cap
-0.6
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--137.03%
Net Income
Estimate
--49.91%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cyclerion Therapeutics, Inc.
CYCN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CYCN
EBIT FORECAST
EBIT Forecast Chart CYCN
NET INCOME FORECAST
Net Income Chart CYCN